The DOI matches its Crossref record; 8 of the 9 references it cites were found in a registry or an index.
What reinfections mean for COVID-19
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reinfections have been reported internationally since June, 2020, although they remain uncommon.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Singanayagam, A., Patel, M., Charlett, A., Lopez Bernal, J., Saliba, V., Ellis, J., Ladhani, S., Zambon, M., & Gopal, R. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.32.2001483 · Cited by 846
Seasonal coronavirus protective immunity is short-lasting
Edridge, A. W. D., Kaczorowska, J., Hoste, A. C. R., Bakker, M., Klein, M., Loens, K., Jebbink, M. F., Matser, A., Kinsella, C. M., Rueda, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1083-1 · Cited by 767
Genomic evidence for reinfection with SARS-CoV-2: a case study
Tillett, R. L., Sevinsky, J. R., Hartley, P. D., Kerwin, H., Crawford, N. F., Gorzalski, A. J., Laverdure, C., Verma, S. C., Rossetto, C. C., Jackson, D. K., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30764-7 · Cited by 755
To, K. K.-W., Hung, I. F.-N., Ip, J. D., Chu, A. W.-H., Chan, W.-M., Tam, A. R., Fong, C. H.-Y., Yuan, S., Tsoi, H.-W., Ng, A. C.-K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1275 · Cited by 746
Elslande, J. V., Vermeersch, P., Vandervoort, K., Wawina-Bokalanga, T., Vanmechelen, B., Wollants, E., Laenen, L., André, E., Ranst, M. A. V., Lagrou, K., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1330 · Cited by 271
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
Dearlove, B. L., Lewitus, É., Bai, H., Li, Y., Reeves, D. B., Joyce, M. G., Scott, P. T., Amare, M. F., Vasan, S., Michael, N. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008281117 · Cited by 206
Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain.
Elslande, J. V., Vermeersch, P., Vandervoort, K., Wawina-Bokalanga, T., Vanmechelen, B., Wollants, E., Laenen, L., André, E., Ranst, M. A. V., Lagrou, K., et al. (2020) · Clinical Infectious Diseases · Cited by 133
Prado-Vivar, B., Becerra-Wong, M., Guadalupe, J. J., Márquez, S., Gutiérrez, B., Rojas‐Silva, P., Grunauer, M., Trueba, G. A., Barragán, V., & Cárdenas, P. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3686174 · Cited by 91
Research works printed but not linked: 1
- To, 2020, COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing, Clin Infect Dis
Cited by
Sorted by citations
Items 101–200 of 227
Yang, D., Lin, F.-C., Tsai, P.-H., Chien, Y., Wang, M., Yang, Y., & Chang, T.-J. (2021) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000542 · Cited by 11
Nationwide assessment of energy costs and policies to limit airborne infection risks in U.S. schools
Cai, J., Li, S., Hu, D., Xu, Y., & He, Q. (2021) · Journal of Building Engineering · doi:10.1016/j.jobe.2021.103533 · Cited by 12
An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19
Soleimanian, S., Alyasin, S. S., Sepahi, N., Ghahramani, Z., Kanannejad, Z., Yaghobi, R., & Karimi, M. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.884879 · Cited by 11
Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data
Reynolds, S. L., Kaufman, H. W., Meyer, W. A., Bush, C., Cohen, O. J., Cronin, K. A., Kabelac, C. A., Leonard, S., Anderson, S., Petkov, V. I., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280584 · Cited by 13
Recent advances in the vaccine development for the prophylaxis of SARS Covid-19
Kumar, V., Kumar, S., & Sharma, P. C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109175 · Cited by 10
Post pandemic fatigue: what are effective strategies?
Yuan, Z., Musa, S. S., Hsu, S., Cheung, C. M., & He, D. (2022) · Scientific Reports · doi:10.1038/s41598-022-13597-0 · Cited by 10
Shah, J. N., Samson, P., Pradhan, N. M. S., Maharjan, S., Shrestha, A., Shah, J., Shah, J., & Sarala, K. C. (2021) · Journal of Patan Academy of Health Sciences · doi:10.3126/jpahs.v8i2.37287 · Cited by 9
Pan, L., Wang, R., Yu, N. H., Hu, C., Yan, J., Zhang, X., Wang, T., Hao, J., Gao, F., Liu, T., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04151-9 · Cited by 9
HOW COVID-19 PATIENT NARRATIVES CONCERNING REINFECTION MIRROR THEIR MENTAL HEALTH: A CASE SERIES
Deng, Y., Wang, L., Yang, J., Xie, L., & Chen, Y. (2021) · Psychiatria Danubina · doi:10.24869/psyd.2021.114 · Cited by 9
Possas, C. D. A., Antunes, A. M. D. S., de Oliveira, A. M., Mendes, C. D. D. S., Ramos, M. P., Schumacher, S. D. O. R., & Homma, A. (2021) · Circular Economy and Sustainability · doi:10.1007/s43615-021-00051-y · Cited by 10
Cooper, I., Mondal, A., Antonopoulos, C. G., & Mishra, A. (2022) · Nonlinear Dynamics · doi:10.1007/s11071-022-07347-0 · Cited by 9
Sabetian, G., Shahriarirad, S., Moghadami, M., Asmarian, N., Askarian, M., Askarian, M., Haghighi, L. H. F., & Javadi, P. (2021) · Research Square · doi:10.30476/ijms.2023.97708.2951 · Cited by 10
Prasad, R. M., Srivastava, S., Wang, E., Liu, J. Z., Gami, R., AbdelGadir, A., Sharma, A., Rayamajhi, S., & Tikaria, R. (2021) · The Permanente Journal · doi:10.7812/tpp/21.035 · Cited by 6
Natarajan, H., Xu, S., Crowley, A. R., Butler, S. E., Weiner, J. A., Bloch, E. M., Littlefield, K. E., Benner, S. E., Shrestha, R., Ajayi, O., et al. (2022) · BMC Immunology · doi:10.1186/s12865-022-00480-w · Cited by 7
Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2
Kršák, M., Harry, B. L., Palmer, B. E., & Franco‐Paredes, C. (2021) · Viral Immunology · doi:10.1089/vim.2021.0054 · Cited by 8
Gandolfi, D., Pagnoni, G., Filippini, T., Goffi, A., Vinceti, M., D'Angelo, E. U., & Mapelli, J. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.724362 · Cited by 7
Persistent SARS-CoV-2 positivity
Ferrari, A., Alfano, G., & Guaraldi, G. (2021) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001043 · Cited by 7
COVID-19-Omics Report: From Individual Omics Approaches to Precision Medicine
Louis, I. V.-S., Fang, D., Amer, Y., & Mohei, H. (2023) · Reports — Medical Cases Images and Videos · doi:10.3390/reports6040045 · Cited by 8
A fractional complex network model for novel corona virus in China
El-Saka, H. A. A., Obaya, I., & Agiza, H. N. (2021) · Advances in Difference Equations · doi:10.1186/s13662-020-03182-y · Cited by 7
SARS-COV-2, can you be over it?
Fiocchi, A., & Jensen-Jarolim, E. (2021) · The World Allergy Organization Journal · doi:10.1016/j.waojou.2021.100514 · Cited by 6
Manica, M., Pancheri, S., Poletti, P., Giovanazzi, G., Guzzetta, G., Trentini, F., Marziano, V., Ajelli, M., Zuccali, M. G., Benetollo, P. P., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab556 · Cited by 8
El-Menyar, A. A., Khan, N. A., Mekkodathil, A. A., Rizoli, S. B., Consunji, R. J., Elmenyar, E., Galwankar, S. C., & Al-Thani, H. A. S. (2022) · Medicine · doi:10.1097/md.0000000000030609 · Cited by 7
Emergency use authorisation of Covid-19 vaccines:An ethical conundrum
Vashishtha, V. M., & Kumar, P. (2020) · Indian Journal of Medical Ethics · doi:10.20529/ijme.2020.122 · Cited by 7
Ophthalmological manifestations of post-COVID-19 syndrome
Yusef, Y. N., Kazaryan, E. E., Анджелова, Д. В., & Vorobyova, M. V. (2021) · Russian Annals of Ophthalmology · doi:10.17116/oftalma2021137052331 · Cited by 7
Preventing COVID-19 Fatalities: State versus Federal PoliciesPreprint
Renne, J., Roussellet, G., & Schwenkler, G. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3720947 · Cited by 7
COVID-19: a confirmed case of reinfection in a nurse
Scarpati, G., Piazza, O., Pagliano, P., & Rizzo, F. M. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-244507 · Cited by 6
Lee, J., Cho, K., Kook, H., Kang, S., Lee, Y., & Lee, J. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.67203 · Cited by 6
The potential of developing a protective peptide‐based vaccines against SARS‐CoV‐2
Shalash, A. O., Tóth, I., & Skwarczyński, M. (2022) · Drug Development Research · doi:10.1002/ddr.21969 · Cited by 6
Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS-CoV-2
Valk, S. J., Piechotta, V., Kimber, C., Chai, K. L., Monsef, I., Doree, C. J., Wood, E. M., Lamikanra, A., Roberts, D. J., McQuilten, Z., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013802 · Cited by 6
Gao, L., Mu, X., Jiao, Y., & Wang, F. (2021) · Infectious Diseases & Immunity · doi:10.1097/id9.0000000000000027 · Cited by 6
Re-positive PCR of SARS-CoV-2 in health care persons during COVID-19 pandemic
Alebouyeh, M., Aavani, P., Abdulrahman, N., Haleem, A. A., Karimi, A., Armin, S., Fallah, F., Amirali, A., Sadr, S., Ghandchi, G., et al. (2022) · Cellular and Molecular Biology · doi:10.14715/cmb/2021.67.5.19 · Cited by 6
Activity-driven network modeling and control of the spread of two concurrent epidemic strains
Burbano-L., D. A., Zino, L., Butail, S., Caroppo, E., Jiang, Z., Rizzo, A., & Porfiri, M. (2022) · Applied Network Science · doi:10.1007/s41109-022-00507-6 · Cited by 6
Beriaín, Í. D. M., & Rueda, J. (2021) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2021.102079 · Cited by 6
The COVID-19 Vaccine in Clinical Trials: Where Are We Now?
Jiang, H.-D., Li, J., Zhang, P., Huo, X., & Zhu, F. (2021) · Infectious Diseases & Immunity · doi:10.1097/id9.0000000000000003 · Cited by 6
What we know and don’t know on SARS-CoV-2 and COVID-19
Silva-Ayarza, I., & Bachelet, V. C. (2021) · Medwave · doi:10.5867/medwave.2021.04.8198 · Cited by 7
Recurrent COVID-19 infection in a health care worker: a case report
Garg, J., Agarwal, J., Das, A., & Sen, M. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-021-02881-8 · Cited by 5
A lateral flow test detecting SARS-CoV-2 neutralizing antibodiesPreprint
Zhang, N., Chen, S., Wu, J. V., Yang, X., & Wang, J. J. (2020) · medRxiv · doi:10.1101/2020.11.05.20222596 · Cited by 5
Yamasaki, L., & Moi, M. L. (2021) · Pathogens · doi:10.3390/pathogens10101262 · Cited by 4
Post-vaccination reactions occurring in patients vaccinated against SARS-COV-2
Wróblewska, I. M., Wróblewska, Z. M., Grudzień, R., Dziechciaż, M., Czabak-Garbacz, R., Choina, P., & Chmielewski, J. P. (2021) · Medycyna Ogólna i Nauki o Zdrowiu · doi:10.26444/monz/145063 · Cited by 4
Pokharel, K., Dawadi, B. R., Aryal, B., & Shrestha, L. B. (2022) · Journal of Chitwan Medical College · doi:10.54530/jcmc.591 · Cited by 4
Garrido, J. M., Martínez‐Rodríguez, D., Rodríguez‐Serrano, F., Sferle, S. M., & Villanueva, R. J. (2021) · Mathematics · doi:10.3390/math9101132 · Cited by 4
Association of Results of Four Lateral Flow Antibody Tests with Subsequent SARS-CoV-2 Infection
Findlater, L., Trickey, A., Jones, H. E., Trindall, A., Taylor‐Phillips, S., Mulchandani, R., EDSAB-HOME investigators, Oliver, I., & Wyllie, D. H. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02468-22 · Cited by 4
Reinfection or relapse of COVID-19 in health care workers; case series of 2 patients from Pakistan
Ahmed, A., Sana, F., Ikram, A., Yousaf, S., & Khan, A. H. (2021) · New Microbes and New Infections · doi:10.1016/j.nmni.2021.100896 · Cited by 4
Evaluation of the United States COVID-19 Vaccine Allocation StrategyPreprint
Islam, M. R., Oraby, T. F., McCombs, A., Chowdhury, M. M., Al-Mamun, M., Tyshenko, M. G., & Kadelka, C. (2021) · medRxiv · doi:10.1101/2021.07.01.21259870 · Cited by 4
Why decoding the immune response to COVID matters for vaccines
(2020) · Nature · doi:10.1038/d41586-020-02943-9 · Cited by 3
Looi, K. H. (2023) · Journal of Public Health Research · doi:10.1177/22799036231197192 · Cited by 3
CORTICOSTEROIDS AND SECONDARY INFECTIONS: AN INSIGHT INTO CORONAVIRUS DISEASE-2019
Neela, B., Jakkula, S. V., MUJEEBUDDIN, & Gaur, R. P. (2021) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2021.v14i1.40096 · Cited by 3
Epidemiological characteristics, reinfection possibilities and vaccine development of SARS CoV2
Yadav, R., Bajpai, P. K., Srivastava, D. K., & Kumar, R. (2021) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2151_20 · Cited by 3
End-to-end SARS-CoV-2 transmission risks in sport: Current evidence and practical recommendations
Jones, B. L., Phillips, G., Valeriani, F., Edwards, T., Adams, E. R., Bonadonna, L., Copeland, R., Cross, M., Dalton, C., Hodgson, L., et al. (2021) · South African Journal of Sports Medicine · doi:10.17159/2078-516x/2021/v33i1a11210 · Cited by 3
COVID-19: Current Challenges and Future Perspectives
Leggat, P., Frean, J., & Blumberg, L. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-3119-9 · Cited by 4
Epidemiological and clinical characteristics of SARS-CoV-2 reinfections in a Spanish region
Yuguero, O., Companys, M., Guzmán, M., Maciel, R., Llobet, C., López, A., Olles, R., Pujol, V., Ruiz, M. J. H., Saura, M., et al. (2022) · SAGE Open Medicine · doi:10.1177/20503121221108556 · Cited by 3
Turabián, J. L. (2022) · International Journal of Epidemiology and Health Sciences · doi:10.51757/ijehs.3.2022.253909 · Cited by 3
Comparison of nasopharyngeal samples for SARS‐CoV ‐2 detection in a paediatric cohort
Rodrigues, J. L. N., Gouveia, C., Santos, M., Costa, O., Côrte‐Real, R., & Brito, M. J. (2021) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.15405 · Cited by 3
Anand, A., Kumar, S., & Ghosh, P. (2021) · Epidemiologic Methods · doi:10.1515/em-2021-0034 · Cited by 3
Ricke‐Hoch, M., Stelling, E., Laßwitz, L., Gunesch, A.-P., Kasten, M., Belinchón, F. J. Z., Brogden, G., Gerold, G., Battmer, K., Pietschmann, T., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-129664/v1 · Cited by 3
The COVID-19 Pandemic: Socioeconomic and Health DisparitiesPreprint
Javaheri, B. (2021) · Preprints.org · doi:10.20944/preprints202012.0599.v2 · Cited by 3
Reynolds, S. L., Kaufman, H. W., Meyer, W. A., Bush, C., Cohen, O. J., Cronin, K. A., Kabelac, C. A., Leonard, S., Anderson, S., Petkov, V. I., et al. (2022) · medRxiv · doi:10.1101/2022.02.25.22271515 · Cited by 3
Devi, A., Adak, A., & Gupta, P. K. (2024) · Journal of Applied Mathematics and Computing · doi:10.1007/s12190-024-02073-9 · Cited by 2
Convalescent plasma for people with COVID-19
Iannizzi, C., Chai, K. L., Piechotta, V., Monsef, I., Wood, E. M., Lamikanra, A., Roberts, D. J., McQuilten, Z. K., So‐Osman, C., Jindal, A., et al. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600.pub7 · Cited by 2
Biswas, R. K., Afiaz, A., Huq, S., Farzana, M., & Kabir, E. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.06.050 · Cited by 2
Montasser, I. F., Dabbous, H. M., Salah, M. M., Massoud, Y. M., Ebada, H. E., Sakr, M. M., Atef, S., Bahaa, M., & Meteini, M. E. (2021) · Journal of Liver Transplantation · doi:10.1016/j.liver.2021.100002 · Cited by 2
Dariotis, J. K., Sloane, S. M., & Smith, R. L. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-021-03033-8 · Cited by 2
Bindra, A., Sharma, N., Joseph, S., Mathur, P., Malhotra, R., & Khan, M. A. (2021) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2021.362 · Cited by 2
The changing dynamics of neutralizing antibody response within 10 months of SARS‐CoV‐2 infections
Baştuğ, A., Bodur, H., Aydos, Ö., Filazi, N., Öksüz, E., & Özkul, A. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27544 · Cited by 2
Mukherjee, S., Jayasekera, H. W., Vincent, C. K., Hoptroff, M., Yekhe, A. S., & Tobery, T. W. (2022) · Medical Research Archives · doi:10.18103/mra.v10i10.3186 · Cited by 2
Awada, H., Nassereldine, H., & Ali, A. H. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-021-02965-5 · Cited by 2
The COVID-19 Pandemic: Socioeconomic and Health DisparitiesPreprint
Javaheri, B. (2020) · Preprints.org · doi:10.20944/preprints202012.0599.v1 · Cited by 2
İkiışık, H., Çağ, Y., Sezerol, M. A., Sürmeli, A., Taşçı, Y., Şahin, Ç. E., & Maral, İ. (2021) · Research Square · doi:10.21203/rs.3.rs-296853/v1 · Cited by 2
Unlocking capacities of viral genomics for the COVID-19 pandemic responsePreprint
Knyazev, S., Chhugani, K., Sarwal, V., Ayyala, R., Singh, H., Karthikeyan, S., Deshpande, D., Comarova, Z., Lu, A., Porozov, Y. B., et al. (2021) · PubMed · doi:10.48550/arxiv.2104.14005 · Cited by 2
Primer caso de reinfección confirmada por SARS-CoV-2 en el Perú
Pampa-Espinoza, L., García, M., Gavilán, R. G., Donaires, F., Cabezas, C., Rojas, N., Palomino, M., Huaringa, M., Rios, P., Gonzales-Valdez, H., et al. (2021) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2021.382.7848 · Cited by 2
Kimotho, J., Sein, Y., Sayed, S., Shah, R., Mwai, K., Saleh, M. N., Wanjiku, P., Mwacharo, J. K., Nyagwange, J., Karanja, H., et al. (2022) · medRxiv · doi:10.1101/2022.10.05.22280716 · Cited by 2
Fine, P., Mulholland, K., Scott, J. A. G., & Edmunds, W. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00078-5 · Cited by 1
SARS-CoV-2 Reinfection Rate: A Systematic Review and Meta-analysis
Alimohamadi, Y., Bahani, K., Alimohamadi, K., & Sepandi, M. (2023) · Infection Epidemiology and Microbiology · doi:10.52547/iem.9.1.63 · Cited by 1
Kimotho, J., Sein, Y., Sayed, S., Shah, R., Mwai, K., Saleh, M. N., Wanjiku, P., Mwacharo, J. K., Nyagwange, J., Karanja, H., et al. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.19414.1 · Cited by 2
Zino, L., Ye, M., & Anderson, B. D. O. (2024) · IFAC Journal of Systems and Control · doi:10.1016/j.ifacsc.2024.100262 · Cited by 1
Evidence for immunity to SARS-CoV-2 from epidemiological data series
Yubero, P., Lavin, A. A., & Poyatos, J. F. (2021) · F1000Research · doi:10.12688/f1000research.28482.2 · Cited by 1
COVID-19 and Promising Expected Vaccines
Suliman, N. (2021) · Open Access Journal of Biomedical Science · doi:10.38125/oajbs.000253 · Cited by 1
COVID-19 Reinfection and its Diagnostic Approach
William, A., & Kaur, R. (2021) · American Journal of Applied Sciences · doi:10.3844/ajassp.2021.71.78
CORONAVIRUS VACCINE DEVELOPMENT: FROM SARS AND MERS TO COVID-19 (RUSSIAN TRANSLATION)
Li, Y.-D., Chi, W.-Y., Su, J.-H., Ferrall, L., Hung, C., & Wu, T. ‐. (2020) · Juvenis scientia · doi:10.32415/jscientia_2020_6_6_41-80 · Cited by 1
Distinguishing repeated polymerase chain reaction positivity from re‐infections in COVID‐19
Sadr, S., Bafrani, M. A., Abdollahi, A., SeyedAlinaghi, S., Mohammadnejad, E., Hossienzade, R., ShahmariGolestan, F., Ahmadinejad, Z., Salehi, M., Javaherian, M., et al. (2021) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12883 · Cited by 1
COVID-19 Reinfection in a Young Medical Doctor: A Case Report
Gaire, D., Sah, M., & Singh, B. M. (2021) · Journal of Nepal Medical Association · doi:10.31729/jnma.6450
Is Laps of Time Since Malaria Elimination a Factor in COVID-19 Mortality?
Raham, T. F. (2022) · Biomedicine and Chemical Sciences · doi:10.48112/bcs.v1i2.97 · Cited by 1
Churiso, G., Diriba, K., Girma, H., & Tafere, S. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s370907 · Cited by 1
Symptomatic reinfection with COVID-19: A case-report study in Iran
Kalurazi, T. Y., Amini‐Salehi, E., Rahimi-Shamami, S., Poursmail, R., Joukar, F., Hassanipour, S., & Mansour‐Ghanaei, F. (2022) · Journal of Current Biomedical Reports · doi:10.52547/jcbior.3.2.98 · Cited by 1
Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
Pallett, S. J. C., Jones, R., Randell, P. A., Davies, G., & Moore, L. S. P. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30990-7 · Cited by 1
Serological Evidence for Reinfection with SARS-CoV-2; An Observational Cohort StudyPreprint
van Binnendijk, R. S., den Hartog, G., Reimerink, J. H. J., Schepp, R. M., Feenstra, S. G., Reukers, D. F. M., Reusken, C. B. E. M., Eggink, D., Sanders, E. A. M., Kortbeek, T., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3800076 · Cited by 1
Safe and effective pool testing for SARS-CoV-2 detectionPreprint
Wunsch, M., Aschemeier, D., Heger, E., Ehrentraut, D., Krüger, J., Hufbauer, M., Syed, A. S., Horemheb-Rubio, G., Dewald, F., Fish, I., et al. (2021) · medRxiv · doi:10.1101/2021.04.08.20205781 · Cited by 1
Optimization Algorithm Based on Novelty Search Applied to the Treatment of Uncertainty in Models
Martínez‐Rodríguez, D. (2021) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/178994 · Cited by 1
Opinion: Early COVID-19 testing in Peru and its implications on transmissionPreprint
Delgado-Diaz, D. J., Zuniga-Gutierrez, M. A., Narh, C. A., & Richards, J. S. (2021) · doi:10.31219/osf.io/nkc25 · Cited by 1
Containing COVID: “To Trace or Not to Trace?” - That Is Not the Question!Preprint
Enaganti, I., Chatterjee, S., Meel, K. S., & Mishra, B. (2022) · Preprints.org · doi:10.20944/preprints202204.0020.v1 · Cited by 1
Sadr, S., Bafrani, M. A., Abdollahi, A., SeyedAlinaghi, S., Mohammadnejad, E., Hossienzade, R., Golestan, F. S., Ahmadinejad, Z., Salehi, M., Javaherian, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-271345/v1
Ehmann, R. K., & Gürtler, L. G. (2021) · Trillium Diagnostik · doi:10.47184/td.2021.01.04
Reinfección por virus del sarscov-2 en un trabajador de la salud
Ospina, C. E. G., & López, K. L. B. (2021) · Archivos de Medicina (Manizales) · doi:10.30554/archmed.21.2.4162.2021
Towards Bayesian Evaluation of Seroprevalence Studies
Fürstová, J., Krátká, Z., Fürst, T., Strojil, J., & Vencálek, O. (2021) · International Electronic Conference on Environmental Research and Public Health (ECERPH) · doi:10.3390/ecerph-3-09006
SARS-CoV-2 re-positivity within the first 3 months of COVID-19 recovery; probable re-infectionPreprint
Sadr, S., Bafrani, M. A., Abdollahi, A., SeyedAlinaghi, S., Mohammadnejad, E., Hossienzade, R., Golestan, F. S., Ahmadinejad, Z., Salehi, M., Javaherian, M., et al. (2021) · doi:10.22541/au.162117445.56254867/v1
SARS-CoV-2 reinfection: Two cases from Ethiopia
Huluka, D. K., Gebray, N., Aberra, B., Yilak, G., Sherman, C. B., & Wolday, D. (2021) · Journal of the Pan African Thoracic Society · doi:10.25259/jpats_7_2021
Respuesta inmunitaria ante la infecci�n por SARS-CoV-2
Escamilla-Tilch, M., Téllez‐González, M. A., Campillo-Navarro, M., Suárez‐Cuenca, J. A., & Mondragón‐Terán, P. (2021) · Revista de especialidades m�dico-quir�rgicas · doi:10.24875/remq.m21000003
Re-Infection by SARS-Cov-2 with in 5 Months: A Case Report
Gamez, L. D.-M., Ibarra-Valencia, E. A., Meza-Ledesma, M. A., Flores-Vargas, G., Navarro-Olivos, E., Gallardo-Luna, M. D. J., & Raygoza, N. P. (2021) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2160
A clinical case of the novel coronavirus (COVID-19) reinfection in a health care worker
Kovtyukh, I. V., Gendlin, G. E., Nikitin, I. G., Kabirova, E. V., & Markina, O. Y. (2021) · Russian Medicine · doi:10.17816/0869-2106-2021-27-2-195-200
COVID-19 vaccination drive in India – Beginning of the end
Bansal, R., & Bansal, P. (2021) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_294_21
Metadata
- Authors
- Iwasaki, A.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Iwasaki, Akiko
- ORCID
- Iwasaki, Akiko
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 21
- Issue
- 1
- Pages
- 3-5
- ISSN
- 1473-3099 (ISSN-L)
- PMC
- PMC7550040
- OpenAlex
- W3092033637
- Cited by
- 230
- References
- 9
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 8 · 2023: 19 · 2022: 46 · 2021: 136
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Update notices
- erratum (2021-01-01)
- Open access
- bronze
- doi.org
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Keywords
- COVID-19 pandemic, SARS-CoV-2, reinfection, immune response, protective immunity, duration of immunity
- MeSH terms
- Reinfection, COVID-19, SARS-CoV-2, Humans, Recurrence, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
